Delivery Order SPE2DB20D3103-SPE2DB23FL5C9
Award Date
11/2/22
Potential Completion Date
11/3/22
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,053.00 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product used in healthcare settings. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVDBZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,714.60 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,183.70, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.52 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 28, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,734.90, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has a completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,615.78 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2024 with a completion date of August 27, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,675.60 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,219.10, is a Firm Fixed Price Delivery Order for VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical supply product. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with a value of $2,503.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a completion date of March 5, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a...